Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

Simple Moving Average

Exponential Moving Average

Relative Strength Index

Standard Deviation

Williams %R

Average Directional Index

Insider Trading

Neutral

Wall Street Data Solutions Rating

()

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

N/A

Shares Outstanding

N/A

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

N/A

Last Div

N/A

Range

N/A

Chg

N/A

Avg Vol

N/A

Mkt Cap

N/A

Exch

N/A

Country

N/A

Phone

N/A

DCF Diff

N/A

DCF

N/A

Div Yield

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

Div Yield %

N/A

P/E

N/A

PEG

N/A

Payout

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash Ratio

N/A

DSO

N/A

DIO

N/A

Op Cycle

N/A

DPO

N/A

CCC

N/A

Gross Margin

N/A

Op Margin

N/A

Pretax Margin

N/A

Net Margin

N/A

Eff Tax Rate

N/A

ROA

N/A

ROE

N/A

ROCE

N/A

NI/EBT

N/A

EBT/EBIT

N/A

EBIT/Rev

N/A

Debt Ratio

N/A

D/E

N/A

LT Debt/Cap

N/A

Total Debt/Cap

N/A

Int Coverage

N/A

CF/Debt

N/A

Equity Multi

N/A

Rec Turnover

N/A

Pay Turnover

N/A

Inv Turnover

N/A

FA Turnover

N/A

Asset Turnover

N/A

OCF/Share

N/A

FCF/Share

N/A

Cash/Share

N/A

OCF/Sales

N/A

FCF/OCF

N/A

CF Coverage

N/A

ST Coverage

N/A

CapEx Coverage

N/A

Div&CapEx Cov

N/A

P/BV

N/A

P/B

N/A

P/S

N/A

P/E

N/A

P/FCF

N/A

P/OCF

N/A

P/CF

N/A

PEG

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

DPS

N/A

Latest Headlines (EST)

GlobeNewswire Inc. Jun 24, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 24, 00:41 Fortrea Holdings Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Pending Against FTRE GlobeNewswire Inc. Jun 22, 18:16 ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE GlobeNewswire Inc. Jun 22, 13:33 FTRE FRAUD ALERT: Fortrea Holdings Inc. Investors are Reminded of Ongoing Securities Fraud Class Action -- Contact BFA Law by August 1 Legal Deadline (NASDAQ:FTRE) The Motley Fool Jun 21, 20:03 The Smartest Dividend Stocks to Buy With $100 Right Now GlobeNewswire Inc. Jun 18, 23:00 Reliance Global Group Announces Up To $6.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules GlobeNewswire Inc. Jun 17, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 14, 11:48 FTRE SHAREHOLDERS: Fortrea Holdings Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by August 1 Deadline (NASDAQ:FTRE) GlobeNewswire Inc. Jun 12, 21:44 SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea GlobeNewswire Inc. Jun 12, 01:11 Class Action Filed: Fortrea Holdings Inc. Investors with Losses Urged to Contact Johnson Fistel GlobeNewswire Inc. Jun 10, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat and Fortrea and Encourages Investors to Contact the Firm Benzinga Jun 08, 14:20 Elon Musk-Trump Clash Propelled This Stock To Weekly High: Here's A List Of Other Top Performing Large Cap Gainers (Jun 2-Jun 6) GlobeNewswire Inc. Jun 07, 22:30 Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color GlobeNewswire Inc. Jun 07, 00:00 FTRE Investor Notice: Stockholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Against Fortrea Holdings, Inc. GlobeNewswire Inc. May 30, 05:00 Communiqué de presse : L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO GlobeNewswire Inc. May 30, 05:00 Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials GlobeNewswire Inc. May 30, 05:00 Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies GlobeNewswire Inc. May 23, 00:57 Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock Benzinga Apr 30, 21:25 STEM Mentorship Event Brings Together LA Dodgers Foundation and SoCalGas to Inspire the Next Generation of STEM Professionals GlobeNewswire Inc. Apr 30, 21:00 Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update

Revenue Product Segmentation